ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 232 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169,299,811 | +156.3% | 344,364 | +103.2% | 0.16% | +171.7% |
| Q2 2023 | $66,047,586 | +33.6% | 169,470 | +27.8% | 0.06% | +27.7% |
| Q1 2023 | $49,420,502 | -8.3% | 132,644 | -6.7% | 0.05% | -11.3% |
| Q4 2022 | $53,865,459 | -6.7% | 142,189 | -13.0% | 0.05% | -8.6% |
| Q3 2022 | $57,730,000 | -7.7% | 163,519 | -0.9% | 0.06% | 0.0% |
| Q2 2022 | $62,548,000 | -11.6% | 165,086 | -26.5% | 0.06% | +9.4% |
| Q1 2022 | $70,788,000 | -9.7% | 224,504 | +0.2% | 0.05% | 0.0% |
| Q4 2021 | $78,434,000 | -8.4% | 223,975 | -21.0% | 0.05% | -13.1% |
| Q3 2021 | $85,583,000 | +14.8% | 283,387 | +14.4% | 0.06% | +17.3% |
| Q2 2021 | $74,575,000 | +44.7% | 247,699 | +32.3% | 0.05% | +36.8% |
| Q1 2021 | $51,548,000 | – | 187,180 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 39,370 | $14,917,000 | 13.60% |
| Tri Locum Partners LP | 82,735 | $31,347,000 | 12.84% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,493,000 | 9.48% |
| Artal Group S.A. | 400,000 | $151,552,000 | 8.10% |
| Finepoint Capital LP | 52,800 | $20,005,000 | 6.92% |
| Paradigm Biocapital Advisors LP | 88,816 | $33,651,000 | 6.71% |
| Fairmount Funds Management LLC | 73,526 | $27,858,000 | 6.38% |
| DCF Advisers, LLC | 25,000 | $9,472,000 | 5.64% |
| Redmile Group, LLC | 385,818 | $146,179,000 | 5.58% |
| Eagle Health Investments LP | 60,300 | $22,846,000 | 5.33% |